Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study.
Abstract | BACKGROUND AND DESIGN: RESULTS: CONCLUSION: Short-term treatment with calcipotriol ointment (50 micrograms/g) used in amounts up to about 100 g/wk is moderately efficacious, well-tolerated, and safe in adult patients with various ichthyoses.
|
Authors | K Kragballe, P M Steijlen, H H Ibsen, P C van de Kerkhof, J Esmann, L H Sorensen, M B Axelsen |
Journal | Archives of dermatology
(Arch Dermatol)
Vol. 131
Issue 5
Pg. 556-60
(May 1995)
ISSN: 0003-987X [Print] United States |
PMID | 7741542
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Dermatologic Agents
- Ointments
- Pharmaceutical Vehicles
- Placebos
- calcipotriene
- Calcitriol
|
Topics |
- Adolescent
- Adult
- Aged
- Calcitriol
(administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
- Child
- Darier Disease
(drug therapy)
- Dermatologic Agents
(administration & dosage, adverse effects, therapeutic use)
- Double-Blind Method
- Drug Eruptions
(etiology)
- Female
- Humans
- Ichthyosis
(drug therapy)
- Ichthyosis Vulgaris
(drug therapy)
- Ichthyosis, X-Linked
(drug therapy)
- Keratoderma, Palmoplantar
(drug therapy, genetics)
- Keratosis
(drug therapy, metabolism)
- Male
- Middle Aged
- Ointments
- Pharmaceutical Vehicles
- Placebos
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|